![Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome | Article Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome | Article](https://assets.cureus.com/uploads/figure/file/338142/article_show_82158fd0988b11ec86841deb1a69af7c-Screenshot-2022-02-28-at-16.50.20.webp)
Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome | Article
![Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis](https://www.frontiersin.org/files/Articles/774079/fmed-08-774079-HTML/image_m/fmed-08-774079-g001.jpg)
Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig1_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![JCM | Free Full-Text | Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting JCM | Free Full-Text | Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting](https://www.mdpi.com/jcm/jcm-09-02851/article_deploy/html/images/jcm-09-02851-g004.png)
JCM | Free Full-Text | Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting
![Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches](https://pub.mdpi-res.com/diagnostics/diagnostics-12-00407/article_deploy/html/images/diagnostics-12-00407-g001-550.jpg?1644571167)
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
![Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches](https://pub.mdpi-res.com/diagnostics/diagnostics-12-00407/article_deploy/html/images/diagnostics-12-00407-g002.png?1644571167)
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig2_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment](https://www.frontiersin.org/files/Articles/615978/fmed-08-615978-HTML/image_m/fmed-08-615978-g001.jpg)
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
![JCM | Free Full-Text | Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting JCM | Free Full-Text | Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting](https://www.mdpi.com/jcm/jcm-09-02851/article_deploy/html/images/jcm-09-02851-g001.png)